VITALE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 10.974
AS - Asia 4.035
EU - Europa 3.841
SA - Sud America 579
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 89
OC - Oceania 7
Totale 19.628
Nazione #
US - Stati Uniti d'America 10.772
GB - Regno Unito 1.457
SG - Singapore 1.215
CN - Cina 1.128
IT - Italia 693
VN - Vietnam 445
HK - Hong Kong 443
BR - Brasile 442
SE - Svezia 356
DE - Germania 308
BD - Bangladesh 203
FR - Francia 181
UA - Ucraina 165
FI - Finlandia 164
RU - Federazione Russa 163
CA - Canada 112
KR - Corea 111
IN - India 100
TR - Turchia 97
IE - Irlanda 88
BG - Bulgaria 68
AR - Argentina 40
ID - Indonesia 37
MX - Messico 36
JP - Giappone 32
NL - Olanda 32
IQ - Iraq 30
ZA - Sudafrica 30
AE - Emirati Arabi Uniti 29
CO - Colombia 26
ES - Italia 25
PK - Pakistan 24
MY - Malesia 21
VE - Venezuela 21
PL - Polonia 20
BE - Belgio 19
CL - Cile 18
EC - Ecuador 17
BY - Bielorussia 15
SA - Arabia Saudita 13
UZ - Uzbekistan 13
PH - Filippine 12
CR - Costa Rica 11
LT - Lituania 10
TH - Thailandia 10
CZ - Repubblica Ceca 9
MA - Marocco 9
PT - Portogallo 9
PY - Paraguay 9
TT - Trinidad e Tobago 9
EG - Egitto 8
NP - Nepal 8
AT - Austria 7
AZ - Azerbaigian 7
JM - Giamaica 7
RO - Romania 7
TN - Tunisia 7
AL - Albania 6
DO - Repubblica Dominicana 6
KE - Kenya 6
KZ - Kazakistan 6
AU - Australia 5
DZ - Algeria 5
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
CH - Svizzera 4
EE - Estonia 4
ET - Etiopia 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
SI - Slovenia 4
TW - Taiwan 4
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
HN - Honduras 3
LY - Libia 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 19.506
Città #
Ashburn 1.237
Southend 1.111
Santa Clara 860
Fairfield 804
Singapore 765
Woodbridge 562
Chandler 465
Hong Kong 430
San Jose 414
Houston 409
Hefei 366
Seattle 362
Jacksonville 347
Wilmington 293
Dearborn 291
Cambridge 290
Ann Arbor 288
Council Bluffs 263
Los Angeles 258
Chicago 252
Beijing 231
Nyköping 201
London 165
New York 144
Ho Chi Minh City 126
The Dalles 118
Modena 117
Helsinki 101
Hanoi 96
Seoul 93
Salt Lake City 92
Dallas 88
Dublin 85
Princeton 75
Milan 72
San Diego 68
Buffalo 66
Sofia 64
Eugene 57
Toronto 54
Izmir 53
Lauterbourg 51
Moscow 48
São Paulo 47
Phoenix 44
Elk Grove Village 42
Des Moines 41
Columbus 39
Frankfurt am Main 36
Boardman 35
Atlanta 33
Longmont 33
Bremen 32
Munich 30
Orem 30
Tampa 30
Tokyo 29
Redwood City 28
Fremont 27
Rome 27
Falls Church 26
Brooklyn 25
Lancaster 25
Chennai 23
Da Nang 23
Haiphong 22
Miami 22
Sterling 22
Denver 21
Shanghai 21
Bologna 20
Springfield 19
San Francisco 18
Brussels 17
Norwalk 17
Naples 16
Warsaw 16
Boston 15
Jakarta 15
Johannesburg 15
Pittsburgh 15
Ferrara 14
Montreal 14
Washington 14
Detroit 13
Las Vegas 13
Mexico City 13
Parma 13
Seongnam 13
Paris 12
Tashkent 12
Amsterdam 11
Biên Hòa 11
Kansas City 11
Newark 11
Poplar 11
Rio de Janeiro 11
Wuhan 11
Baghdad 10
Dhaka 10
Totale 13.556
Nome #
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 521
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 512
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 478
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 447
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 445
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 432
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 413
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 413
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 409
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 391
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 388
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 383
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 380
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 374
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 373
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 372
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 370
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 360
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 347
Gamma-hydroxybutyrate increases gastric emptying in rats 334
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 332
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 328
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 327
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 326
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 320
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 312
Disposition of naproxen after oral administration during and between migraine attacks. 305
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 304
Effect of rofecoxib on nociception and the serotonin system in the rat brain 299
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 298
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 290
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 290
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 287
In vitro toxicity of fibrous glaucophane 284
Headaches associated with chronic use of analgesics: A therapeutic approach 283
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 273
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 271
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 271
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 270
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 267
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 264
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 261
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 260
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 257
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 256
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 251
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 251
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 250
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 245
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 241
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 236
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 234
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 228
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 227
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 223
Naloxone-reverisble antinociception by paracetamol in the rat. 222
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 222
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 203
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 195
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 191
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 187
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 177
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 173
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 149
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 146
Totale 19.628
Categoria #
all - tutte 74.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022965 0 0 0 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20266.379 405 273 437 779 1.126 448 648 297 598 523 463 382
2026/20271.582 250 598 450 284 0 0 0 0 0 0 0 0
Totale 19.628